Why the study?
The global burden of chronic kidney disease is rising, with arterial hypertension acting as a key factor driven by complex systemic signaling pathways that induce kidney injury.
Key points are not available for this paper at this time.
Design
Review
Interplay of AT1R, HIFα, and mechanotransduction pathways may drive hypertensive kidney injury; leaves open targeted therapies for prospective validation.
The global burden of chronic kidney disease is rising. The etiologies, heterogeneous, and arterial hypertension, are key factors contributing to the development and progression of chronic kidney disease. Arterial hypertension is induced and maintained by a complex network of systemic signaling pathways, such as the hormonal axis of the renin-angiotensin-aldosterone system, hemodynamic alterations affecting blood flow, oxygen supply, and the immune system. This review summarizes the clinical and histopathological features of hypertensive kidney injury and focusses on the interplay of distinct systemic signaling pathways, which drive hypertensive kidney injury in distinct cell types of the kidney. There are several parallels between hypertension-induced molecular signaling cascades in the renal epithelial, endothelial, interstitial, and immune cells. Angiotensin II signaling via the AT1R, hypoxia induced HIFα activation and mechanotransduction are closely interacting and further triggering the adaptions of metabolism, cytoskeletal rearrangement, and profibrotic TGF signaling. The interplay of these, and other cellular pathways, is crucial to balancing the injury and repair of the kidneys and determines the progression of hypertensive kidney disease.
No takes yet. Share an insight, caveat, or question.
Sievers et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: